SCHEMBL29446267

SCHEMBL29446267

O=Cc1ccc(OCc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR2 P21452 1/20 0.62
▸ MAOA P21397 1/20 0.61
▸ MAOB P27338 1/20 0.61
▸ ALDH1A1 P00352 6/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.59
▸ LMNA P02545 2/20 0.58
▸ GSK3B P49841 1/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ KMT2A Q03164 2/20 0.57
▸ POLB P06746 1/20 0.57
▸ UBE2N P61088 1/20 0.57
▸ SIRT2 Q8IXJ6 1/20 0.57
▸ MAPT P10636 4/20 0.54
▸ NPC1 O15118 2/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ HTT P42858 2/20 0.54
▸ ADAMTS5 Q9UNA0 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ PDCD1 Q15116 1/20 0.52
▸ CD274 Q9NZQ7 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL584489 1.00 TACR2 (0.62) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL1609108 0.92 TACR2 (0.75) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL662145 0.92 TACR2 (0.75) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL29721221 0.91 TACR2 (0.54) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL5215156 0.91 TACR2 (0.61) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL5216320 0.91 TACR2 (0.78) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL5213944 0.91 TACR2 (0.54) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL9077155 0.91 TACR2 (0.54) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL752160 0.91 ALDH1A1 (0.65) TACR2MAOAMAOBALDH1A1SMN1; SMN2
SCHEMBL29377794 0.91 ALDH1A1 (0.65) TACR2MAOAMAOBALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120040333-A Preparation method of 5, 6-dihydroxyindoline 北京成宇化工有限公司 2025-05-27 — — CN claimed
CN-117924143-A Preparation method of 5, 6-dihydroxyindole 北京成宇化工有限公司 2024-04-26 — — CN claimed
CN-120040333-B Preparation method of 5, 6-dihydroxyindoline 北京成宇化工有限公司 2025-12-02 — — CN disclosed
CN-120698867-A Preparation method of 4-ethoxy-3-hydroxybenzaldehyde 枣阳市福星化工有限公司 2025-09-26 — — CN disclosed
CN-120040333-A Preparation method of 5, 6-dihydroxyindoline 北京成宇化工有限公司 2025-05-27 — — CN disclosed
CN-120040333-A Preparation method of 5, 6-dihydroxyindoline 北京成宇化工有限公司 2025-05-27 — — CN disclosed
WO-2025019587-A1 SENOTHERAPEUTIC COMPOUNDS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2025-01-23 — — WO disclosed
CN-118878451-A Preparation method and application of cis-2, 3-disubstituted indoline compound 郑州大学 2024-11-01 — — CN disclosed
CN-118878430-A Compound, synthesis method thereof and synthesis method of 5, 6-dihydroxyindole 谱尼生物医药科技(上海)有限公司 2024-11-01 — — CN disclosed
CN-114096551-B With A2A2-Benzylidene hydrazino adenosines with adenosine receptor agonistic activity 中国人民解放军军事科学院军事医学研究院 2024-08-13 — — CN disclosed
EP-4392402-A1 SYNTHESIS ROUTES TO ACCESS MDMA PRODRUGS BY USING CONTROLLED AND NON-CONTROLLED INTERMEDIATES Mind Medicine, Inc. (US) 2024-07-03 — — EP disclosed
CN-112513010-B Enzymatic process for preparing droxidopa 意大利合成制造有限公司 2023-05-23 — — CN disclosed
CN-112011580-B Method for preparing droxidopa and application 宁波酶赛生物工程有限公司 2023-03-31 — — CN disclosed
CN-115850334-A Triphenylphosphonium-hydroxytyrosol, synthesis method thereof and application thereof in preparing drugs for inhibiting cancer cell proliferation 西安交通大学 2023-03-28 — — CN disclosed
WO-2023028022-A1 SYNTHESIS ROUTES TO ACCESS MDMA PRODRUGS BY USING CONTROLLED AND NON-CONTROLLED INTERMEDIATES Mind Medicine, Inc. (US) 2023-03-02 — — WO disclosed
WO-2023004046-A1 COMPOUNDS AND METHODS FOR DETECTION OF SUPEROXIDE PROMEGA CORPORATION (US) 2023-01-26 — — WO disclosed
CN-110099893-B Preparation method of droxidopa and intermediate thereof 广东东阳光药业有限公司 2022-09-27 — — CN disclosed
CN-114641282-A P62 ligand compound and ER-autophagy promoting use thereof 普罗泰克株式会社 2022-06-17 — — CN disclosed
CN-114195640-A Synthetic process of hydroxytyrosol and intermediate thereof 攀枝花学院 2022-03-18 — — CN disclosed
CN-114127070-A Having a2A6-hydrazinoadenosines with adenosine receptor agonist activity 中国人民解放军军事科学院军事医学研究院 2022-03-01 — — CN disclosed
Send feedback